GNI Group Ltd. (TYO:2160)
Japan · Delayed Price · Currency is JPY 2,627.00
+47.00 (1.82%)
Jun 3, 2026, 3:15 PM JST
GNI Group Market Cap
GNI Group has a market cap or net worth of 143.85 billion as of June 2, 2026. Its market cap has increased by 23.58% in one year.
Market Cap
143.85B
Enterprise Value
129.64B
Revenue
27.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,627.00
Market Cap Chart
Since August 31, 2007, GNI Group's market cap has increased from 5.24B to 143.85B, an increase of 2,647.35%. That is a compound annual growth rate of 19.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 143.85B | 7.15% |
| Dec 30, 2025 | 134.25B | -21.38% |
| Dec 30, 2024 | 170.75B | 21.35% |
| Dec 29, 2023 | 140.72B | 112.73% |
| Dec 30, 2022 | 66.15B | -5.89% |
| Dec 30, 2021 | 70.29B | -10.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takara Bio | 137.63B |
| PeptiDream | 135.35B |
| SanBio Company | 100.83B |
| Nxera Pharma | 93.20B |
| Oncolys BioPharma | 80.97B |
| Healios K.K. | 44.01B |
| Cuorips | 40.92B |
| Japan Tissue Engineering | 24.69B |